Role of Mir-155 in the Regulation of MMP-16 Expression in Intervertebral Disc Degeneration.

Wei-Lin Zhang,Yu-Fei Chen,Hong-Zheng Meng,Jun-Jie Du,Guan-Nan Luan,Hai-Qiang Wang,Mao-Wei Yang,Zhuo-Jing Luo
DOI: https://doi.org/10.1002/jor.23313
2017-01-01
Journal of Orthopaedic Research
Abstract:The molecular mechanisms of intervertebral disc degeneration (IDD) remain elusive. We found that miR-155 is downregulated in degenerative nucleus pulposus (NP), and more severe degeneration is correlated with higher matrix metallopeptidase 16 (MMP-16) expression. MMP-16 also degraded matrix aggrecan. Here, we addressed the in vivo miR-155-mediated pathological impact on IDD using a classic puncture mouse model. Lentiviral upregulated-miR-155 or downregulated-miR-155 was transduced into the discs of C57 mice, which was validated by real-time polymerase chain reaction (real-time PCR) and in situ hybridization. Immunohistochemistry and western blotting revealed that up-regulation of miR-155 resulted in down-regulation of MMP-16 and an increase in aggrecan and collagen type II in mouse NP; whereas, down-regulation of miR-155 resulted in up-regulation of MMP-16 and a decrease in aggrecan in mouse NP. Radiographic and histological analysis showed that the up-regulation of miR-155 attenuated IDD, while down-regulation of miR-155 resulted in the deterioration of IDD. These findings indicate that decreased miR-155 contributed to the up-regulation of MMP-16 in vivo, and MMP-16 further degraded aggrecan and collagen type II, leading to the dehydration and degeneration of discs. Our findings revealed a therapeutic role for miR-155 in IDD. (C) 2017 The Authors. Journal of Orthopaedic Research Published by Wiley Periodicals, Inc.
What problem does this paper attempt to address?